These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19077384)

  • 1. National registries of systemic treatment for psoriasis and the European 'Psonet' initiative.
    Lecluse LL; Naldi L; Stern RS; Spuls PI
    Dermatology; 2009; 218(4):347-56. PubMed ID: 19077384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European biologicals registers: methodology, selected results and perspectives.
    Zink A; Askling J; Dixon WG; Klareskog L; Silman AJ; Symmons DP
    Ann Rheum Dis; 2009 Aug; 68(8):1240-6. PubMed ID: 18647854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PsoReg--the Swedish registry for systemic psoriasis treatment. The registry's design and objectives.
    Schmitt-Egenolf M
    Dermatology; 2007; 214(2):112-7. PubMed ID: 17341858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of ciclosporin in psoriasis: a clinical review.
    Ho VC
    Br J Dermatol; 2004 May; 150 Suppl 67():1-10. PubMed ID: 15115440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges for synthesising data in a network of registries for systemic psoriasis therapies.
    Ormerod AD; Augustin M; Baker C; Chosidow O; Cohen AD; Dam TN; Garcia-Doval I; Lecluse LL; Schmitt-Egenolf M; Spuls PI; Watson KD; Naldi L
    Dermatology; 2012; 224(3):236-43. PubMed ID: 22678413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis therapy in real life: the need for registries.
    Schmitt-Egenolf M
    Dermatology; 2006; 213(4):327-30. PubMed ID: 17135739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review.
    Christophers E; Griffiths CE; Gaitanis G; van de Kerkhof P
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):921-5. PubMed ID: 16922938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
    Alwawi EA; Krulig E; Gordon KB
    Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term data in the treatment of psoriasis.
    Thaçi D
    Br J Dermatol; 2008 Aug; 159 Suppl 2():18-24. PubMed ID: 18700911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
    Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological therapies in the systemic management of psoriasis: International Consensus Conference.
    Sterry W; Barker J; Boehncke WH; Bos JD; Chimenti S; Christophers E; De La Brassinne M; Ferrandiz C; Griffiths C; Katsambas A; Kragballe K; Lynde C; Menter A; Ortonne JP; Papp K; Prinz J; Rzany B; Ronnevig J; Saurat JH; Stahle M; Stengel FM; Van De Kerkhof P; Voorhees J
    Br J Dermatol; 2004 Aug; 151 Suppl 69():3-17. PubMed ID: 15265063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing use of more potent treatments for psoriasis.
    Strowd LC; Yentzer BA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2009 Mar; 60(3):478-81. PubMed ID: 19058875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infectious risk].
    Calabuig E; Salavert M
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
    Kircik L
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology].
    Puig L; Bordas X; Carrascosa JM; Daudén E; Ferrándiz C; Hernanz JM; López-Estebaranz JL; Moreno JC; Sánchez-Carazo JL; Vanaclocha F; Vázquez-Veiga H;
    Actas Dermosifiliogr; 2009 May; 100(4):277-86. PubMed ID: 19463230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to managing patients with nail psoriasis.
    Reich K
    J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():15-21. PubMed ID: 19686381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriol and betamethasone dipropionate for the treatment of psoriasis: a 52-week study.
    Toole JW
    Skin Therapy Lett; 2007 May; 12(4):1-3. PubMed ID: 17551662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
    Puig L
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries.
    Garcia-Doval I; Rustenbach SJ; Stern R; Dam TN; Cohen AD; Baker C; Spuls PI; Naldi L;
    Br J Dermatol; 2013 Sep; 169(3):710-4. PubMed ID: 23551034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.